Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study
暂无分享,去创建一个
H. Büller | E. Sijbrands | J. Kastelein | E. de Groot | B. Hutten | H. D. Bakker | A. Wiegman | J. Rodenburg | Eric J G Sijbrands | J. Kastelein | Eric de Groot | H. R. Büller | Eric J. G. Sijbrands | Ericc de Groot | John J. P. Kastelein | B. A. Hutten | J. Kastelein | E. D. Groot
[1] J. Kastelein,et al. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. , 2002, Journal of the American College of Cardiology.
[2] G. R. Warnick,et al. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. , 1990, Clinical chemistry.
[3] H. Mabuchi,et al. Development of coronary heart disease in familial hypercholesterolemia. , 1989, Circulation.
[5] H. Büller,et al. W16-O-005 Efficacy and safety of statin therapy in children with familial hypercholesterolemia , 2005 .
[6] G. Schwartz,et al. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. , 1978, The Journal of pediatrics.
[7] J. H. MacMillan,et al. Detection of silent coronary artery disease in adolescents and young adults with familial hypercholesterolemia by single-photon emission computed tomography thallium-201 scanning. , 1992, The American journal of cardiology.
[8] E. Sijbrands,et al. Family History and Cardiovascular Risk in Familial Hypercholesterolemia: Data in More Than 1000 Children , 2003, Circulation.
[9] M. Trip,et al. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial , 2001, The Lancet.
[10] D. Illingworth,et al. Indications for low-density lipoprotein apheresis. , 1994, The American journal of cardiology.
[11] J. Kastelein,et al. Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia. , 2002, Atherosclerosis.
[12] M. Mercuri,et al. Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Trial With Simvastatin , 2002, Circulation.
[13] A. Folsom,et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.
[14] Eary,et al. CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .
[15] E. Sijbrands,et al. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia , 2004, The Lancet.
[16] Olli T. Raitakari,et al. Increased Aortic Intima-Media Thickness: A Marker of Preclinical Atherosclerosis in High-Risk Children , 2001, Circulation.
[17] S. Tonstad,et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[18] A. Gotto. Targeting high-risk young patients for statin therapy. , 2004, JAMA.
[19] H. Büller,et al. Short-Term Efficacy and Safety of Pravastatin in 72 Children with Familial Hypercholesterolemia , 1996, Pediatric Research.
[20] A. Zwinderman,et al. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study , 2002, The Lancet.
[21] P. Hopkins,et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. , 1999, JAMA.
[22] B. Friis‐Hansen,et al. 41: Neonatal Diagnosis of Familial Type II Hyperlipoprotein emia , 1976, Pediatric Research.
[23] B. Friis‐Hansen,et al. Neonatal diagnosis of familial type II hyperlipoproteinemia. , 1976, Pediatrics.
[24] R. Levy,et al. Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. , 1974, The Journal of clinical investigation.
[25] J. T. Clarke,et al. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. , 1996, Pediatrics.
[26] R H Selzer,et al. The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events , 1998, Annals of Internal Medicine.
[27] R. Levy,et al. Neonatal diagnosis of familial type-II hyperlipoproteinaemia. , 1973, Lancet.
[28] J. Kastelein,et al. The molecular basis of familial hypercholesterolemia in The Netherlands , 2001, Human Genetics.
[29] A. Di Costanzo,et al. Increased intima-media thickness of the common carotid artery in hypercholesterolemic children. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.